BrainStorm Cell Therapeutics
BCLI
#10513
Rank
A$10.64 M
Marketcap
A$0.96
Share price
-1.43%
Change (1 day)
-53.16%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -A$16.97 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$16.25 Million, an increase over its 2023 earnings that were of -A$24.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$16.97 Million4.42%
2024 -A$16.25 Million-32.39%
2023 -A$24.04 Million-29.18%
2022 -A$33.94 Million-0.74%
2021 -A$34.2 Million-23.12%
2020 -A$44.48 Million36.8%
2019 -A$32.51 Million66.71%
2018 -A$19.5 Million181.66%
2017 -A$6.93 Million-0.6%
2016 -A$6.97 Million-41.31%
2015 -A$11.87 Million-8.22%
2014 -A$12.93 Million89.74%
2013 -A$6.82 Million42.27%
2012 -A$4.79 Million-12.45%
2011 -A$5.48 Million63.04%
2010 -A$3.36 Million35.52%
2009 -A$2.48 Million-48.99%
2008 -A$4.86 Million-44.39%
2007 -A$8.73 Million
2005 -A$4.52 Million-91.44%
2004 -A$52.82 Million94007.62%
2003 -A$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
A$2.26 B-15,064.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.69 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.11 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.16 Billion 7,549.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$28.88 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-A$0.36 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA